Patents by Inventor Shelia Violette

Shelia Violette has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070009518
    Abstract: The present invention is directed to methods for treating fibrosis conditions, such as liver, kidney and lung fibrosis, as well as fibrosis conditions of other tissues of the body. The methods of the invention comprise administering to a patient in need of such treatment a therapeutically effective amount of a B-cell antagonist. Exemplary B-cell antagonists that can be used in the practice of the methods of the invention include antibodies against B-cell surface antigens (e.g., antibodies against CD20), and BAFF antagonists.
    Type: Application
    Filed: May 18, 2006
    Publication date: January 11, 2007
    Applicant: Biogen Idec Inc.
    Inventors: Tatiana Novobrantseva, Shelia Violette, Victor Kotelianski, Alexander Ibraghimov
  • Publication number: 20050255102
    Abstract: Monoclonal antibodies that specifically bind to M.96. Also included are methods of using these antibodies to treat mammals having or at risk of having 006-mediated diseases, or to diagnose % Qmediated diseases.
    Type: Application
    Filed: March 13, 2003
    Publication date: November 17, 2005
    Inventors: Shelia Violette, Paul Weinreb, Kenneth Simon, Dean Sheppard, Diane Leone